Is Zhenoluten FDA approved
No. This profile records Zhenoluten as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE OVARIAN RESTORER
A-15 Ovary Bioregulator Peptide
Zhenoluten is a bioregulator peptide derived from ovarian tissue that helps restore hormonal balance and ovarian function. It works by enhancing the genes that control follicular development and hormone production. Particularly valuable for women experiencing premature ovarian decline, perimenopause, or fertility challenges.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Zhenoluten as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 20 mg orally each morning.
Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Upregulates GDF9, BMP15, and FOXL2 for healthy follicle maturation
Increases STAR and CYP19A1 for enhanced estrogen/progesterone production
Restores hypothalamic-pituitary-ovarian signaling via epigenetic modification
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.